Topic Uterine Leiomyoma

Viewing 1–1 of 1

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Oral Gonadotrophin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas *6181*
Professions: Physician

Price: $25.00
Credits:
- ACOG 2.0 CME
Planner
{{ evaluation.question.text }}

{{choice.text}}

{{evaluation.answerSet[0].text}}
Test Code: ONG0523

Published: April 6, 2023

Expires: 5/31/2026

Sources: Obstetrics & Gynecology
Details

Required Passing Score: 7/10 (70%)

Authors: Michael F. Neblett II, MD, and Elizabeth A. Stewart, MD

Categories: Gynecological , Management , Obstetrical , Women's Health

Specialties: OB/GYN

Topics: Oral Gonadotrophin-Releasing Hormone (GnRH) , Uterine Leiomyoma

Media:

Viewing 1–1 of 1

Lippincott CMEConnection